Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Raw Materials (2016 - 2018)

Historic Raw Materials for Anika Therapeutics (ANIK) over the last 8 years, with Q3 2018 value amounting to $13.2 million.

  • Anika Therapeutics' Raw Materials rose 6831.07% to $13.2 million in Q3 2018 from the same period last year, while for Sep 2018 it was $13.2 million, marking a year-over-year increase of 6831.07%. This contributed to the annual value of $11.3 million for FY2017, which is 9197.82% up from last year.
  • As of Q3 2018, Anika Therapeutics' Raw Materials stood at $13.2 million, which was up 6831.07% from $12.6 million recorded in Q2 2018.
  • Anika Therapeutics' 5-year Raw Materials high stood at $13.2 million for Q3 2018, and its period low was $4.9 million during Q3 2015.
  • Over the past 5 years, Anika Therapeutics' median Raw Materials value was $6.3 million (recorded in 2017), while the average stood at $7.4 million.
  • As far as peak fluctuations go, Anika Therapeutics' Raw Materials crashed by 2895.64% in 2015, and later surged by 10012.72% in 2018.
  • Quarter analysis of 5 years shows Anika Therapeutics' Raw Materials stood at $6.2 million in 2014, then dropped by 6.2% to $5.8 million in 2015, then increased by 1.8% to $5.9 million in 2016, then soared by 91.98% to $11.3 million in 2017, then rose by 17.22% to $13.2 million in 2018.
  • Its last three reported values are $13.2 million in Q3 2018, $12.6 million for Q2 2018, and $10.1 million during Q1 2018.